Astellas Pharma Inc. has announced that its Phase 2 GLEAM trial evaluating zolbetuximab in combination with gemcitabine plus nab-paclitaxel for metastatic pancreatic adenocarcinoma did not
This past September, the urothelial cancer field witnessed several groundbreaking developments, offering new hope for patients and fresh strategies for clinicians. As reported by OncLive.com,
Illumina, Inc. has unveiled its groundbreaking 5-base solution, setting a new standard for multiomic research by enabling scientists to simultaneously analyze genomic and epigenomic information
Editor’s Note: Patient Worthy is proud to share this story from our friends at Elephants & Tea. To see the story in its original format,
Editor’s Note: Patient Worthy is honored to share this article from our friends at Elephants & Tea. To see the article in its original form,
A recent large-scale study has found that individuals diagnosed with narcolepsy face a significantly higher risk of developing cardiovascular disease (CVD) and experiencing major adverse
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as fatty liver disease, affects about one in three adults worldwide and poses major health risks, not
Editor’s Note: Patient Worthy is proud to share this story from GACI Global, originally published by the Italian Osservatorio Malattie Rare (OMaR). ARHR2 –
A groundbreaking study from the University of Oulu, recently published in Proceedings of the National Academy of Sciences (PNAS), sheds new light on the role
When we are faced with an obstacle, big or small, we supposedly pick one of two options: to fight it or to run away. Nowadays,
A recently published study in The Lancet reports that over 54,600 children living in Gaza are severely malnourished. In addition, as of August 2025, there
Biomarker analysis plays a pivotal role in cancer care and research, guiding the development of targeted therapies and enabling personalized treatment plans. While next-generation sequencing
Alkermes is set to present detailed positive results from its Vibrance-1 Phase 2 study of alixorexton, a novel, once-daily oral orexin 2 receptor agonist, in
Your liver is a powerhouse organ, responsible for processing nutrients, detoxifying your blood, and managing everything from cholesterol to vitamins. Diet plays a vital role
Merck has announced a significant expansion of its clinical development program for tulisokibart (MK-7240), an investigational monoclonal antibody targeting the inflammatory mediator TL1A. Reported by
Excessive daytime sleepiness (EDS) is more than just feeling tired—it can be a debilitating symptom of two distinct neurological disorders: hypersomnia and narcolepsy. While both
After years of setbacks and uncertainty, Stealth BioTherapeutics has achieved a historic breakthrough with FDA approval of Forzinity (elamipretide), the first treatment for Barth syndrome,
If you live in the Northern Hemisphere, Fall has quickly passed and Winter is upon us. The beginning of Fall is one of favorite times
Today is Chronic Thromboembolic Pulmonary Hypertension (CTEPH) awareness day. CTEPH is a rare form of pulmonary hypertension (PAH) where blood clots in the lungs that can lead to high blood pressure in the lungs and potential heart failure if untreated.
With bringing awareness to this condition we hope to to inform the public and medical professionals about CTEPH, which is caused by old blood clots in the lungs after a pulmonary embolism.
Symptoms:
-Shortness of breath during exercise
-Fatigue
-Chest pain or tightness
-Dizziness or lightheadedness
-Swelling in the legs
-Blueish discoloration of the skin (cyanosis)
CTEPH can be diagnosed by physical exam, chest X-ray, and CT pulmonary angiography (CTPA)
#ctephawareness #PatientWorthy #pah
Patient Worthy is looking for individuals who are interested in sharing their experiences with ATTR-CM. Be the reason someone feels seen, supported, and inspired! Ready to share? Click here: bit.ly/4hX2QCA 📢
#ATTRCM #AmyloidosisAwareness #hearthealth #RareDisease #shareyourstory #PatientWorthy
November 12th is World Pneumonia Day, a time to remember those affected and to commit to raising awareness about this life-threatening disease. Prevention saves lives. #WorldPneumoniaDay #PneumoniaAwareness #pneumonia #PatientWorthy
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
